gsk jemperli news - Search News

GSK, Jemperli

GSK announces FDA granted BTD for Jemperli

GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for Jemperli for the treatment of patients with locally advanced mismatch repair deficient/microsatellite instability-high,

Business Insider · 3d

GSK announces CHMP of the EMA recommended expanding approval of Jemperli

GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding

MarketWatch · 3d

GSK Jemperli Gets Positive CHMP Opinion

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top

Yahoo Finance · 2d

GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli

In another press release, GSK announced that the CHMP has recommended expanded use of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent ...

3don MSN

GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Wall Street Journal3d

GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion

GSK’sGSK-0.49%decrease; red down pointing triangle cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the ...

阿思達克財經網15h

GSK(GSK.US)单抗一线疗法获FDA突破性疗法认定用于治疗直肠癌

智通财经APP获悉，GSK (GSK.US) 日前宣布，美国FDA已授予其PD-1抑制剂Jemperli (dostarlimab)用于治疗局部晚期错配修复缺陷 (dMMR)/高微卫星不稳定性 (MSI-H)直肠癌的突破性疗法认定 (BTD)。

GSK's Cancer Drug Jemperli Nears EU Marketing Expansion -- 2nd Update

GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the pharmaceutical giant's oncology pipeline.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results